相关实验视频

Updated: Jan 18, 2026

Delivery of In Vivo Acute Intermittent Hypoxia in Neonatal Rodents to Prime Subventricular Zone-derived Neural Progenitor Cell Cultures

Delivery of In Vivo Acute Intermittent Hypoxia in Neonatal Rodents to Prime Subventricular Zone-derived Neural Progenitor Cell Cultures

Published on: November 2, 2015

治疗性急性间歇性缺氧适度改善了佩病患者的呼吸

Angela L Roger¹, Meredith L Huston¹, Madison Spaulding¹

¹Department of Pediatrics, School of Medicine, Duke University, United States.

Respiratory physiology & neurobiology

|September 10, 2025

概括

治疗性急性间歇性缺氧 (tAIH) 通过增强运动神经元功能,改善了庞培病小鼠的呼吸. 这种非侵入性治疗为庞贝患者的呼吸系统问题提供了潜在的新疗法.

科学领域:

神经肌肉疾病神经肌肉疾病
呼吸系统生理学呼吸系统生理学
治疗性缺氧治疗性缺氧

背景情况:

庞培病是一种遗传性疾病,由于酸α-葡萄糖酶 (GAA) 缺乏,导致肌肉衰弱和呼吸困难.
目前的酶替代疗法 (ERT) 因其无法穿越血脑屏障而受到限制,导致运动神经元病理没有得到治疗.
需要替代治疗方法,可以改善Pompe病的运动神经元功能和呼吸系统结果.

研究的目的:

研究治疗性急性间歇性缺氧 (tAIH) 作为改善佩病小鼠模型呼吸功能的一种新疗法的疗效.
探索tAIH增强运动神经元功能和缓解与GAA缺乏相关的呼吸道症状的潜力.

主要方法:

成年GAA小鼠 (庞培病模型) 和野生型 (WT) 小鼠接受了tAIH协议.
该方案包括一周的初始治疗,然后每两周进行一次治疗,持续4个月.
评估了呼吸反应,化学反射激活,阴影和神经肌肉结合.

主要成果:

短期和长期的tAIH治疗都在GAA小鼠中显示出适度的呼吸改善.
长期的tAIH治疗在WT小鼠中适度提高了呼吸反应.
佩小鼠的改善可能与增强的化学反射,减少的形和更好的神经肌肉结合功能有关.

结论:

治疗性急性间歇性缺氧 (tAIH) 显示出作为改善佩病呼吸功能的一种非侵入性治疗的潜力.
tAIH可以增强运动神经元功能和神经肌肉传播,提供有前途的替代或辅助疗法.
需要进一步的研究来探索tAIH对佩患者的机制和临床适用性.

关键词:

急性间歇性缺氧是什么化学反射激活的激活方式神经肌肉结节的神经肌肉结节庞贝病是庞贝病的一种疾病.呼吸系统呼吸系统呼吸系统

更多相关视频

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

A Model to Simulate Clinically Relevant Hypoxia in Humans

A Model to Simulate Clinically Relevant Hypoxia in Humans

Published on: December 22, 2016

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Physiological Control of Respiration

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...

Acute Respiratory Failure-IV

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...

Hyperpnea and Hyperventilation

Hyperpnea and Hyperventilation

Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...